Media Coverage
What people say about us
Media
- Industry-Academia Collaboration Formed to Improve Cell and Gene Therapy Manufacturing
GEN Eng News - 25.11.2025
- Swiss Biotech: Depth, Breadth & Scaling Up
Pharma Boardroom - 18.11.2025
- Limula’s LimONE System Targets Consistency in Stem Cell Transplants
BioPharm International - 15.09.2025
- Three life sciences startups recognized for growth potential
Startupticker - 04.08.2025
- Regeneration Nation: 5 Swiss Biotechs Rewriting the Rules of Medicine
Pharma Boardroom - 25.06.2025
- BIO2025: Fit-for-Purpose Manufacturing for Personalized Therapy
The Pharma Navigator - 11.06.2025
- Limula: Unlocking the full potential of cell therapies with automation
Verve - 07.06.2025
- Limula’s End-to-End Cell Processing Platform Enters Beta Testing
GEN Eng News - 06.06.2025
- Personalized therapies are transforming medicine
globalance - 29.04.2025
- Breakthrough Solution in end-to-end cell therapy manufacturing unveiled
Startupticker - 07.03.2025
- Limula unveils automated cell therapy tech
BioProcess International - 03.03.2025
- IMD-connected startups raised CHF 350m in 2024
IMD - 14.02.2025
- Limula répond aux besoins des thérapies cellulaires
24heures - 27.05.2024
- Swiss-based Limula raised over €6.2 million aiming to democratise access to life-saving cell and gene therapies
EU Startups - 21.05.2024
- Biotech Limula secures $6.8M for gene therapy
tech.eu - 21.05.2024
- Swiss startup creates modular device for on-demand cell therapy manufacturing
The Next Web - 21.05.2024
Media
- Industry-Academia Collaboration Formed to Improve Cell and Gene Therapy Manufacturing
GEN Eng News - 25.11.2025 - Swiss Biotech: Depth, Breadth & Scaling Up
Pharma Boardroom - 18.11.2025 - Limula’s LimONE System Targets Consistency in Stem Cell Transplants
BioPharm International - 15.09.2025 - Three life sciences startups recognized for growth potential
Startupticker - 04.08.2025 - Regeneration Nation: 5 Swiss Biotechs Rewriting the Rules of Medicine
Pharma Boardroom - 25.06.2025 - BIO2025: Fit-for-Purpose Manufacturing for Personalized Therapy
The Pharma Navigator - 11.06.2025 - Limula: Unlocking the full potential of cell therapies with automation
Verve - 07.06.2025 - Limula’s End-to-End Cell Processing Platform Enters Beta Testing
GEN Eng News - 06.06.2025 - Personalized therapies are transforming medicine
globalance - 29.04.2025 - Breakthrough Solution in end-to-end cell therapy manufacturing unveiled
Startupticker - 07.03.2025 - Limula unveils automated cell therapy tech
BioProcess International - 03.03.2025 - IMD-connected startups raised CHF 350m in 2024
IMD - 14.02.2025 - Limula répond aux besoins des thérapies cellulaires
24heures - 27.05.2024 - Swiss-based Limula raised over €6.2 million aiming to democratise access to life-saving cell and gene therapies
EU Startups - 21.05.2024 - Biotech Limula secures $6.8M for gene therapy
tech.eu - 21.05.2024 - Swiss startup creates modular device for on-demand cell therapy manufacturing
The Next Web - 21.05.2024